Related references
Note: Only part of the references are listed.Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Rupert Courtnay et al.
MOLECULAR BIOLOGY REPORTS (2015)
Normalization of CD4+ T cell metabolism reverses lupus
Yiming Yin et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Choline kinase inhibition in rheumatoid arthritis
M. Guma et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy
D. J. Roberts et al.
CELL DEATH AND DIFFERENTIATION (2015)
T-cell metabolism in autoimmune disease
Zhen Yang et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Metabolism of activated T lymphocytes
Jason A. Maciolek et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients
Georgia McDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Akt Phosphorylation and Regulation of Transketolase Is a Nodal Point for Amino Acid Control of Purine Synthesis
Arindam Saha et al.
MOLECULAR CELL (2014)
Metabolism of stromal and immune cells in health and disease
Bart Ghesquiere et al.
NATURE (2014)
Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate
Alla Fridman et al.
BIOCHEMICAL JOURNAL (2013)
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors
Nunzio Bottini et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Ajit S. Divakaruni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
E. L. Pearce et al.
SCIENCE (2013)
Metabolomics as a Key Integrator for Omic Advancement of Personalized Medicine and Future Therapies
Andrea D. Eckhart et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2012)
A translational study case report on the small molecule energy blocker 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside
Y. H. Ko et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective small molecule anti-cancer agent taken from labside to bedside: introduction to a special issue
Peter L. Pedersen
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
Simone Cardaci et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
3-bromopyruvate: Targets and outcomes
Maria C. Shoshan
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Metabolic checkpoints in activated T cells
Ruoning Wang et al.
NATURE IMMUNOLOGY (2012)
Potential of 18F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies
Vishu Vijayant et al.
WORLD JOURNAL OF RADIOLOGY (2012)
The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis
Anna-Karin H. Ekwall et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
Beatrix Bartok et al.
IMMUNOLOGICAL REVIEWS (2010)
Caspase 1-Independent Activation of Interleukin-1β in Neutrophil-Predominant Inflammation
Monica Guma et al.
ARTHRITIS AND RHEUMATISM (2009)
Inflammatory Cytokines and Hypoxia Contribute to 18F-FDG Uptake by Cells Involved in Pannus Formation in Rheumatoid Arthritis
Tamiko Matsui et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Is Akt the Warburg kinase?-Akt-energy metabolism interactions and oncogenesis
R. Brooks Robey et al.
SEMINARS IN CANCER BIOLOGY (2009)
Polyamines and DNA methylation in childhood leukaemia
R. G. Schipper et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Cadherin-11 in synovial lining formation and pathology in arthritis
David M. Lee et al.
SCIENCE (2007)
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
R. B. Robey et al.
ONCOGENE (2006)
Acid-mediated tumor invasion: a multidisciplinary study
RA Gatenby et al.
CANCER RESEARCH (2006)
Hypoxia inducible factor (HIF) in rheumatology:: low O2!: See what HIF can do!
T Gaber et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt
J Morel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
N Majewski et al.
MOLECULAR CELL (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
The KRN mouse model of inflammatory arthritis
D Kyburz et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2003)
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
JE Wilson
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
Evolving concepts of rheumatoid arthritis
GS Firestein
NATURE (2003)
Molecular imaging of cancer with positron emission tomography
SS Gambhir
NATURE REVIEWS CANCER (2002)
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
K Gottlob et al.
GENES & DEVELOPMENT (2001)
Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase
GC Brown
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2001)
Share Paper
